Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, H.
Right arrow Articles by Ahren, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, H.
Right arrow Articles by Ahren, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 23, Issue 5 650-657, Copyright © 2000 by American Diabetes Association


ARTICLES

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance

H Larsson and B Ahren
Department of Medicine, Lund University, Malmo, Sweden. hillevi.larsson@medfork.mas.lu.se

OBJECTIVE: To characterize in detail the association between insulin sensitivity and islet function in relation to glucose tolerance in nondiabetic subjects. RESEARCH DESIGN AND METHODS: The study included 108 postmenopausal women, aged 57-59 years, with normal glucose tolerance (NGT) or impaired glucose tolerance (IGT) and measured glucose tolerance (World Health Organization, 75 g glucose), insulin sensitivity (euglycemic-hyperinsulinemic clamp), and islet function (the 2-5 min insulin responses [AIR] and glucagon [AGR] responses to 5 g intravenous arginine at fasting, 14 and >25 mmol/l glucose levels). The product of insulin sensitivity and secretion was calculated (disposition index [DI]) and used to study the relationship between the two parameters. RESULTS: Insulin sensitivity and insulin secretion were highly inversely correlated in a hyperbolic manner (r > 0.64, P < 0.001) in women with NGT (n = 71). Women with IGT (n = 37) had reduced insulin sensitivity compared with women with NGT (P = 0.011). The AIRs were not appropriately increased in relation to the reduced insulin sensitivity in the IGT women, demonstrated as reduced DI in IGT compared with NGT (P < 0.001). Further, women with IGT had an increased AGR (P < 0.001) and a reduced glucose inhibition of glucagon secretion (slopeAGR, P = 0.014) compared with women with NGT. In a multivariate regression model including all of the 108 women, 2-h glucose was independently determined by the DI, the AGR, and the slopeAGR (r = 0.63, P < 0.001). CONCLUSIONS: We have shown that both the individual ability to adapt insulin secretion to the ambient insulin sensitivity and the level of glucagon secretion are important parameters for maintenance of NGT. Therefore, islet dysfunction in IGT involves low insulin and high glucagon secretion, which present potential targets for correcting impaired glycemia.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
I. Quesada, E. Tuduri, C. Ripoll, and A. Nadal
Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose homeostasis and diabetes
J. Endocrinol., October 1, 2008; 199(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. Tsuchiyama, T. Takamura, H. Ando, M. Sakurai, A. Shimizu, K.-i. Kato, S. Kurita, and S. Kaneko
Possible Role of {alpha}-Cell Insulin Resistance in Exaggerated Glucagon Responses to Arginine in Type 2 Diabetes
Diabetes Care, October 1, 2007; 30(10): 2583 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Sakaue, S. Ishimaru, D. Ikeda, Y. Ohtsuka, T. Honda, J.-i. Suzuki, Y. Kawakami, J. Ishii, and M. Nishimura
Estimation of beta-cell function from the data of the oral glucose tolerance test
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1575 - E1580.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Abdul-Ghani and R. A. DeFronzo
Fasting Hyperglycemia Impairs Glucose- But Not Insulin-Mediated Suppression of Glucagon Secretion
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1778 - 1784.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. H. Xiang, C. Wang, R. K. Peters, E. Trigo, S. L. Kjos, and T. A. Buchanan
Coordinate Changes in Plasma Glucose and Pancreatic {beta}-Cell Function in Latino Women at High Risk for Type 2 Diabetes.
Diabetes, April 1, 2006; 55(4): 1074 - 1079.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Chang, M. J. Smith, C. J. Bloem, A. T. Galecki, J. B. Halter, and M. A. Supiano
Limitation of the Homeostasis Model Assessment to Predict Insulin Resistance and {beta}-Cell Dysfunction in Older People
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 629 - 634.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
S. Del Prato, R. Miccoli, and G. Penno
Review: The importance of effective early phase insulin secretion
The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 198 - 202.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. W. Yeckel, S. E. Taksali, J. Dziura, R. Weiss, T. S. Burgert, R. S. Sherwin, W. V. Tamborlane, and S. Caprio
The Normal Glucose Tolerance Continuum in Obese Youth: Evidence for Impairment in {beta}-Cell Function Independent of Insulin Resistance
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Jiang and B. B. Zhang
Glucagon and regulation of glucose metabolism
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E671 - E678.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Ahren and O. Thorsson
Increased Insulin Sensitivity Is Associated with Reduced Insulin and Glucagon Secretion and Increased Insulin Clearance in Man
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1264 - 1270.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Del Prato, P. Marchetti, and R. C. Bonadonna
Phasic Insulin Release and Metabolic Regulation in Type 2 Diabetes
Diabetes, February 1, 2002; 51(90001): S109 - 116.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Ahren and H. Larsson
Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal Women
Diabetes, February 1, 2002; 51(90001): S202 - 211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.